Searchable abstracts of presentations at key conferences in endocrinology

ea0021p65 | Clinical practice/governance and case reports | SFEBES2009

A rare case of isolated Cushing's disease from an ACTH and GH staining pituitary adenoma

Ahluwalia Rupa , Vora Jiten

A 31-year-old female presented with menstrual irregularities, weight gain and hirsutism.She was recently diagnosed with type 2 diabetes requiring Metformin therapy.Investigations: Serum cortisol levels failed to suppress on overnight dexamethasone suppression test (ODST) and low dose dexamethasone suppression tests (LDDST) (ODST: unsuppressed cortisol at 343 nmol/l, LDDST 48 h post dexamethasone cortisol of 397 nmol/l). The serum c...

ea0021p104 | Clinical practice/governance and case reports | SFEBES2009

A case of Verner-Morrison syndrome with solitary VIPoma and an incidental serous mucinous adenoma

Ahluwalia Rupa , Mon Aung , Vora Jiten

Introduction: Neuroendocrine tumors (NET) are very rare and often present a diagnostic challenge. They are often misdiagnosed due to non-specific symptoms. We report a rare case of NET presenting to a non endocrine unit.Case: A 72-year-old Caucasian female was referred for refractory diarrhoea with hypokalaemia. In addition, there was history of significant weight loss over few months.She had past medical history of diabetes, hyper...

ea0016p314 | Endocrine tumours | ECE2008

A study on investigations for localizing insulinoma

Ul-Haq Mazhar , Vora Jiten P

We studied the practice of investigations for diagnosing and localising insulinoma in our hospital. We looked at the number of investigations performed before exact localisation of insulinoma.We identified 5 cases that were confirmed on clinical, biochemical or histopathological bases and were recorded on the histopathology and IT database as ‘insulinoma’ from 1986 to 2004. We looked retrospectively at the case notes of these cases.<p class...

ea0034p313 | Pituitary | SFEBES2014

Optochiasmal cavernoma presenting with secondary hypogonadism: a case report

Ahluwalia Rupa , Khan Muhammad , Das Kumar , Sinha Ajay , Vora Jiten

Background: We report a case of a 35-year-old male presenting with pituitary dysfunction secondary to an optochiasmal cavernoma.The gentleman was initially referred with gynaecomastia and biochemical tests consistent with secondary hypogonadism. On further questioning he also reported extremely lethargy, difficulties with weight loss and poor libido. Examination was consistent with features of hypogonadism with reduced body hair, bilateral gynaecomastia ...

ea0034p339 | Reproduction | SFEBES2014

Hyperandrogenism secondary to ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor: a case report

Khan Muhammad , Ahluwalia Rupa , Shore Susannah , Waghorn Alison , Vora Jiten

Backgound: We report a case of a 63-year-old postmenopausal female diagnosed with ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor.Following diagnosis of breast cancer in 2009, requiring mastectomy with adjunctive chemotherapy, she was commenced on anastrozole. Later she noted gradual onset of frontal balding and hirsutism. Biochemistry revealed elevated serum levels of testosterone 13.2 nmol/l (range: <1.9 nmol/l) and androst...

ea0028p107 | Clinical practice/governance and case reports | SFEBES2012

Functioning cardiac paraganglioma with underlying heterozygous SDHD mutation, diagnosed following an acute myocardial infarction- A case report

Ahluwalia Rupa , Hung John , Sreemantula Gayatri , Vora Jiten

Background: We report a case of a 51-year-old man with functioning cardiac paraganglioma diagnosed subsequent to a primary coronary event. Following a myocardial infarction aged 39; he was incidentally found to have a cardiac tumour in the pericardial sac. This was assumed to be benign and followed up with serial imaging. Recent scans suggested a possible paraganglioma with evidence of very slow tumour growth leading to an endocrinology referral. On further questioning he did ...

ea0022p454 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Peptide receptor radionuclide therapy and NETs: how to select patients?

Ahluwalia Rupa , McKane Gail , Vora Jiten , Vinjamuri Sobhan

Neuroendocrine tumors (NETs) are rare tumours arising from the gastroenteropancreatic axis. They are slow growing and often metastatic. Diagnostic workup requires imaging; both anatomical (ultrasound, CT, MRI) and functional (somatostatin receptor scintigraphy, PET).NETs strongly express somatostatin receptors (SSTRs) of five different subtypes (SSTRs1–5) with SSTR2 being the most common. Some NETs reflect hyperactivity of the guanethidine pathway. ...

ea0015p195 | Growth and development | SFEBES2008

Is vertical growth still possible at the age of 30?

Mon Aung , Saunders Simon , Whittingham Pauline , Vora Jiten

A 28-year-man originally from Africa presented with short stature. His height at first clinic visit was 128 cm and there was no family history of short stature. He had pale complexion, lack of facial/body hair and under-developed secondary sexual characteristics consistent with morphology of hypopituitaric dwarfism. Insulin stress test with adequate hypoglycaemia<2.2 mmol/l confirmed flat growth hormone (GH) response (peak <0.5 mU/l) and inadequate cortisol response (p...

ea0013p11 | Bone | SFEBES2007

Alendronate accelerates increases in bone mineral density with growth hormone replacement but may attenuate the anabolic effect of growth gormone replacement on bone in adult growth hormone deficiency

White Helen , Ahmad Aftab , Durham Brian , Fraser William , Vora Jiten

Introduction: Adult Growth Hormone Deficiency (AGHD) is associated with osteoporosis. Underlying mechanisms involved in the pathogenesis include reduced target-organ sensitivity to the effect of PTH. Growth Hormone Replacement (GHR) in AGHD leads to increased PTH target-organ sensitivity and consequently increased bone turnover and bone mineral density (BMD).Aims: We determined the effect of alendronate, given in addition to GHR, on PTH target-organ sens...

ea0038p11 | Bone | SFEBES2015

The effect of oestradiol circadian rhythm on the bone mineral density of adult males

Wijetilleka Sajini , Khan Muhammad , Mon Aung , Joseph Frank , Fraser William , Vora Jiten

Background: Circulating levels of total oestradiol (E2) decrease with age in adult males; the effect of altered E2 circadian rhythm is uncertain. We hypothesised that age-related changes in the circadian rhythm contribute to decreased BMD in older males and investigated this.Methods: Nineteen subjects were studied: six young-healthy (YH) males (mean age (years) 27.3±4.6) with normal BMD, eight older-healthy (OH) males (mean age...